Michail Kokkorakis

Michail Kokkorakis

MD-PhD candidate

MD-PhD candidate

Evidence-Informed Cardiometabolic Medicine 📈

Evidence-Informed Cardiometabolic Medicine 📈

Goran Babarogic Product UX Designer
Goran Babarogic Product UX Designer

Steatotic Liver Disease

Steatotic liver disease, including metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis, is the most prevalent chronic liver condition, affecting more than one-fourth of the global population. My research focuses on the pathophysiology, diagnosis, and management of steatitic liver disease according to the latest advancements in the guidelines and clinical trials.

Premium UX Template for Framer

Steatotic Liver Disease

Steatotic liver disease, including metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis, is the most prevalent chronic liver condition, affecting more than one-fourth of the global population. My research focuses on the pathophysiology, diagnosis, and management of steatitic liver disease according to the latest advancements in the guidelines and clinical trials.

Premium UX Template for Framer

Steatotic Liver Disease

Steatotic liver disease, including metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis, is the most prevalent chronic liver condition, affecting more than one-fourth of the global population. My research focuses on the pathophysiology, diagnosis, and management of steatitic liver disease according to the latest advancements in the guidelines and clinical trials.

Premium UX Template for Framer

Obesity

Obesity is considered the epidemic of the 21st century. So far, only two effective and some suboptimal drugs have been available in the clinician’s therapeutic armamentarium. However, emerging alternatives of novel agents and combination schemes are populating obesity’s therapeutic pipeline. My research focuses on emerging pharmacotherapies undergoing or having completed phase 2 and phase 3 clinical trials ultimately fostering personalized care.

Premium UX Template for Framer


Obesity

Obesity is considered the epidemic of the 21st century. So far, only two effective and some suboptimal drugs have been available in the clinician’s therapeutic armamentarium. However, emerging alternatives of novel agents and combination schemes are populating obesity’s therapeutic pipeline. My research focuses on emerging pharmacotherapies undergoing or having completed phase 2 and phase 3 clinical trials ultimately fostering personalized care.

Premium UX Template for Framer


Data Science

My research focuses on multimodal AI/ML models to stratify risk for prevalent and incident cardiometabolic diseases. Utilizing simple and complex data (i.e., imaging and omics) my algorithms meet clinical significance and are non-inferior or even better to the currently available non-invasive tools.

Premium UX Template for Framer

Data Science

My research focuses on multimodal AI/ML models to stratify risk for prevalent and incident cardiometabolic diseases. Utilizing simple and complex data (i.e., imaging and omics) my algorithms meet clinical significance and are non-inferior or even better to the currently available non-invasive tools.

Premium UX Template for Framer

Obesity

Obesity is considered the epidemic of the 21st century. So far, only two effective and some suboptimal drugs have been available in the clinician’s therapeutic armamentarium. However, emerging alternatives of novel agents and combination schemes are populating obesity’s therapeutic pipeline. My research focuses on emerging pharmacotherapies undergoing or having completed phase 2 and phase 3 clinical trials ultimately fostering personalized care.

Premium UX Template for Framer


Data Science

My research focuses on multimodal AI/ML models to stratify risk for prevalent and incident cardiometabolic diseases. Utilizing simple and complex data (i.e., imaging and omics) my algorithms meet clinical significance and are non-inferior or even better to the currently available non-invasive tools.

Premium UX Template for Framer

Steatotic Liver Disease

Steatotic liver disease, including metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis, is the most prevalent chronic liver condition, affecting more than one-fourth of the global population. My research focuses on the pathophysiology, diagnosis, and management of steatitic liver disease according to the latest advancements in the guidelines and clinical trials.

Premium UX Template for Framer

Steatotic Liver Disease

Steatotic liver disease, including metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis, is the most prevalent chronic liver condition, affecting more than one-fourth of the global population. My research focuses on the pathophysiology, diagnosis, and management of steatitic liver disease according to the latest advancements in the guidelines and clinical trials.

Premium UX Template for Framer

Obesity

Obesity is considered the epidemic of the 21st century. So far, only two effective and some suboptimal drugs have been available in the clinician’s therapeutic armamentarium. However, emerging alternatives of novel agents and combination schemes are populating obesity’s therapeutic pipeline. My research focuses on emerging pharmacotherapies undergoing or having completed phase 2 and phase 3 clinical trials ultimately fostering personalized care.

Premium UX Template for Framer


Data Science

My research focuses on multimodal AI/ML models to stratify risk for prevalent and incident cardiometabolic diseases. Utilizing simple and complex data (i.e., imaging and omics) my algorithms meet clinical significance and are non-inferior or even better to the currently available non-invasive tools.

Premium UX Template for Framer

Obesity

Obesity is considered the epidemic of the 21st century. So far, only two effective and some suboptimal drugs have been available in the clinician’s therapeutic armamentarium. However, emerging alternatives of novel agents and combination schemes are populating obesity’s therapeutic pipeline. My research focuses on emerging pharmacotherapies undergoing or having completed phase 2 and phase 3 clinical trials ultimately fostering personalized care.

Premium UX Template for Framer


Data Science

My research focuses on multimodal AI/ML models to stratify risk for prevalent and incident cardiometabolic diseases. Utilizing simple and complex data (i.e., imaging and omics) my algorithms meet clinical significance and are non-inferior or even better to the currently available non-invasive tools.

Premium UX Template for Framer

Experience 🏥

Experience 🏥

Senior Graduate Medical Intern

Senior Graduate Medical Intern

Senior Graduate Medical Intern

Medisch Spectrum Twente

Medisch Spectrum Twente

May 2024 – Present

May 2024 – Present

Doctoral Researcher

Doctoral Researcher

Doctoral Researcher

Harvard Medical School

Harvard Medical School

Oct 2022 – Present

Oct 2022 – Present

Research Affiliate

Research Affiliate

Research Affiliate

Leiden University Medical Center

Leiden University Medical Center

Feb 2024 – Present

Feb 2024 – Present

Doctoral Researcher

Doctoral Researcher

Doctoral Researcher

University Medical Center Groningen

University Medical Center Groningen

Sep 2022 – Present

Sep 2022 – Present

Junior Graduate Medical Intern

Junior Graduate Medical Intern

Junior Graduate Medical Intern

University Medical Center Groningen

University Medical Center Groningen

Apr 2023 – Apr 2024

Apr 2023 – Apr 2024

Academic Tutor

Academic Tutor

Academic Tutor

University Medical Center Groningen

University Medical Center Groningen

Sep 2022 – Sep 2024

Sep 2022 – Sep 2024

Visiting Scholar

Visiting Scholar

Visiting Scholar

University of Pennsylvania

University of Pennsylvania

Apr 2022 – Sep 2022

Apr 2022 – Sep 2022

Member of the University Council

Member of the University Council

Member of the University Council

University of Groningen

University of Groningen

Sep 2021 – Sep 2022

Sep 2021 – Sep 2022

Education 📚

Education 📚

Doctor of Philosophy (PhD)

Doctor of Philosophy (PhD)

Doctor of Philosophy (PhD)

University of Groningen

University of Groningen

Dec 2023 – Present

Dec 2023 – Present

Doctor of Medicine (MD)

Doctor of Medicine (MD)

Doctor of Medicine (MD)

University of Groningen

University of Groningen

Sep 2022 – Present

Sep 2022 – Present

Bachelor of Science (BSc) in Medicine

Bachelor of Science (BSc) in Medicine

Bachelor of Science (BSc) in Medicine

University of Groningen

University of Groningen

Sep 2019 – Jul 2022

Sep 2019 – Jul 2022

Recent Publications 🖊️

Recent Publications 🖊️

GDF-15 improves the predictive capacity of steatotic liver disease non-invasive tests for incident morbidity and mortality risk for cardio-renal-metabolic diseases and malignancies

Metabolism
(Online ahead of print)

Emerging Pharmacotherapies for Obesity: A Systematic Review

Pharmacological Reviews
(Online ahead of print)

Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies

Pharmacological Reviews
(May 2024)

Resmetirom, the first approved drug for the management of metabolic dysfunction-associated steatohepatitis: trials, opportunities, and challenges

Resmetirom, the first approved drug for the management of metabolic dysfunction-associated steatohepatitis: trials, opportunities, and challenges

Resmetirom, the first approved drug for the management of metabolic dysfunction-associated steatohepatitis: trials, opportunities, and challenges

Metabolism
(March 2024)

Effective questionnaire-based prediction models for type 2 diabetes across several ethnicities: a model development and validation study

EClinicalMedicine
(September 2023)

Honors & Awards 🏆

  • GUF-100 Prize Finalist

    Distinction received for belonging to the top 3 out of >4,200 students of the Faculty of Medical Sciences and for the nomination as a finalist for the GUF-100 Prize of the University of Groningen based on academic, research, and societal achievements.

  • MD-PhD Scholarship

    Admitted to the highly selective Doctorate of Medicine and of Philosophy (MD-PhD) track, fully funded by a scholarship of €100K from the University Medical Center Groningen.

  • Human Space Physiology Training

    1 of 30 students selected from top European universities to participate in a fully funded, highly selective training program of the Space Medicine Team at the European Space Agency Academy’s Training & Learning Facility, ESEC-Galaxia, Belgium. Distinction received upon completion based on outstanding performance (Grade: A).

  • Junior Scientific Masterclass

    Among the top 10% of bachelor medical graduates at the University of Groningen, graduating with Honors and excelling in the innovative scientific training program (Junior Scientific Masterclass).

  • ADF Lab Fund

    Received funding from the Koumenis Lab, Perelman School of Medicine, University of Pennsylvania, to cover living expenses during my research internship, totaling $2,900.

  • UMCG Grant

    Received funding from the University Medical Center Groningen to cover part of my travel expenses for my research internship at the Perelman School of Medicine, University of Pennsylvania, totaling €250.

Honors & Awards 🏆

  • GUF-100 Prize Finalist

    Distinction received for belonging to the top 3 out of >4,200 students of the Faculty of Medical Sciences and for the nomination as a finalist for the GUF-100 Prize of the University of Groningen based on academic, research, and societal achievements.

  • MD-PhD Scholarship

    Admitted to the highly selective Doctorate of Medicine and of Philosophy (MD-PhD) track, fully funded by a scholarship of €100K from the University Medical Center Groningen.

  • Human Space Physiology Training

    1 of 30 students selected from top European universities to participate in a fully funded, highly selective training program of the Space Medicine Team at the European Space Agency Academy’s Training & Learning Facility, ESEC-Galaxia, Belgium. Distinction received upon completion based on outstanding performance (Grade: A).

  • Junior Scientific Masterclass

    Among the top 10% of bachelor medical graduates at the University of Groningen, graduating with Honors and excelling in the innovative scientific training program (Junior Scientific Masterclass).

  • ADF Lab Fund

    Received funding from the Koumenis Lab, Perelman School of Medicine, University of Pennsylvania, to cover living expenses during my research internship, totaling $2,900.

  • UMCG Grant

    Received funding from the University Medical Center Groningen to cover part of my travel expenses for my research internship at the Perelman School of Medicine, University of Pennsylvania, totaling €250.

Podcast 📻

Podcast 📻

Tune in to our Podcast!

Tune in to our Podcast!

Tune in to our Podcast!